It’s estimated that as many as one in four premenopausal women suffer from heavy menstrual bleeding (HMB). Also known as menorrhagia, it is a chronic condition characterised by abnormally heavy or prolonged bleeding. While some cases have a physical cause, such as fibroids (benign uterine tumours) most do not. Common though the condition may be, that doesn’t make it necessarily bearable. HMB not only poses a significant health risk but also interferes with a woman’s physical, emotional, social, and material quality of life. Unfortunately, given cultural sensitivities around menstruation in general, little is done to make women aware of the condition and that treatments are available. A significant long-term study by the University of Nottingham in the UK is helping to change that.
You can read the rest of this article, complete with additional feature content, on the Research Outreach website here. (Opens in new tab)